Jessica Sachs
Chief Tech/Sci/R&D Officer bij COGENT BIOSCIENCES, INC.
Vermogen: 9 072 $ op 29-02-2024
Profiel
Jessica Sachs occupies the position of Chief Medical Officer at Cogent Biosciences, Inc.
Dr. Sachs previously held the position of Senior Medical Director-Clinical Research at Takeda Pharmaceutical Co., Ltd.
and Associate Director at Genzyme Corp.
She received an undergraduate degree from Duke University and a doctorate from Washington University in St. Louis.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
COGENT BIOSCIENCES, INC.
0.00% | 23-01-2024 | 1 296 ( 0.00% ) | 9 072 $ | 29-02-2024 |
Actieve functies van Jessica Sachs
Bedrijven | Functie | Begin |
---|---|---|
COGENT BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01-06-2019 |
Eerdere bekende functies van Jessica Sachs
Bedrijven | Functie | Einde |
---|---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01-04-2017 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2012 |
Opleiding van Jessica Sachs
Washington University in St. Louis | Doctorate Degree |
Duke University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
COGENT BIOSCIENCES, INC. | Health Technology |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |